Skip to search formSkip to main contentSkip to account menu

KP-496

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Bronchial asthma is characterized by chronic airway inflammation. Eosinophils are involved in airway inflammation and play… 
2009
2009
Aims: The aim of this study was to evaluate the effects of inhaled KP-496, a novel dual antagonist for cysteinyl leukotriene… 
2008
2008
KP‐496 is a novel dual antagonist for cysteinyl leukotriene receptor 1 (CysLT1) and thromboxane A2 (TXA2) receptor (TP). The aim… 
2008
2008
Abstract.Objective and design:KP-496 is a novel dual antagonist for leukotriene (LT) D4 and thromboxane (TX) A2 receptors. We…